0001214659-24-009785.txt : 20240522 0001214659-24-009785.hdr.sgml : 20240522 20240522163023 ACCESSION NUMBER: 0001214659-24-009785 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240522 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240522 DATE AS OF CHANGE: 20240522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 24973736 BUSINESS ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 8-K 1 p5212408k.htm
false 0001677077 0001677077 2024-05-22 2024-05-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

____________________________________________________________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

___________________________________________________________________

 

Date of Report (Date of earliest event reported):  May 22, 2024

 

ALZAMEND NEURO, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40483   81-1822909
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (I.R.S. Employer Identification No.)

 

3480 Peachtree Road NE, Second Floor, Suite 103, Atlanta, GA 30326

(Address of principal executive offices) (Zip Code)

 

(844) 722-6333

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  Name of each exchange on which registered
Common Stock, $0.0001 par value   ALZN   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

  
 

 

Item 7.01Regulation FD Disclosure

 

As previously reported under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), on March 26, 2024, Alzamend Neuro, Inc. (the “Company”) was notified by the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) that it had not regained compliance with Nasdaq Listing Rule 5550(b)(2). As a result, unless the Company requested an appeal of this determination, the Staff has determined that the Company’s common stock would be delisted from The Nasdaq Capital Market.

 

The Company requested an appeal of the Staff’s determination to a Hearings Panel (the “Panel”). The Panel heard the Company’s appeal on May 9, 2024. On May 21, 2024, the Company received notice from the Panel that it granted the Company’s request to continue its listing on Nasdaq, subject to the Company demonstrating compliance, on or before September 23, 2024, with Listing Rule 5550(b)(1), which requires stockholder equity of at least $2.5 million (or an alternative listing standard), and satisfying all applicable requirements for continued listing on Nasdaq.

 

On May 22, 2024, the Company issued a press release to announce the Panel’s decision. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

 

In accordance with General Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. This report will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

 

The Securities and Exchange Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and which involve risks, uncertainties and reflect the Registrant’s judgment as of the date of this Current Report on Form 8-K. Forward-looking statements may relate to, among other things, operating results and are indicated by words or phrases such as “expects,” “should,” “will,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.

 

Item 9.01Financial Statements and Exhibits

 

(d)Exhibits:

 

Exhibit No.    Description
99.1   Press Release dated May 22, 2024
     
101   Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).

 

 2 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  ALZAMEND NEURO, INC.  
     
     
Dated: May 24, 2024 /s/ Henry Nisser  
 

Henry Nisser

Executive Vice President and General Counsel

 

 

 

 

3

 

 

 

EX-99.1 2 ex99_1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

 

Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel

 

ATLANTA, GA, May 22, 2024 -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), announced today that the Nasdaq Hearings Panel (“Panel”) granted Alzamend’s request to continue its listing on The Nasdaq Capital Market (“Nasdaq”), subject to Alzamend demonstrating compliance, on or before September 23, 2024, with Listing Rule 5550(b)(1), which requires stockholder equity of at least $2.5 million (the “Stockholder Equity Rule”), and satisfying all applicable requirements for continued listing on Nasdaq.

 

“We appreciate the Panel carefully considering our appeal and its decision granting Alzamend an extension to achieve compliance with the Stockholder Equity Rule,” said Stephan Jackman, the Chief Executive Officer of Alzamend. “We continue to implement the compliance plan that we presented to the Panel and are excited to remain listed on Nasdaq.”

 

For more information on Alzamend, stockholders, investors, and any other interested parties may read Alzamend’s public filings and press releases available under the Investor Relations section at https://www.alzamend.com/ or available at https://www.sec.gov/.

 

About Alzamend Neuro

 

Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s, BD, MDD and PTSD. Our mission is to rapidly develop and market safe and effective treatments. Our current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, salicylate and L-proline, and ALZN002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s. Both of our product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.

 

Forward-Looking Statements

 

This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and Alzamend undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect Alzamend’s business and financial results are included in Alzamend’s filings with the U.S. Securities and Exchange Commission. All filings are available at www.sec.gov and on Alzamend’s website at www.Alzamend.com.

 

Contacts:

Email: Info@Alzamend.com or call: 1-844-722-6333

 

 

 

 

 

 

 

EX-101.SCH 3 alzn-20240522.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 alzn-20240522_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 alzn-20240522_pre.xml XBRL PRESENTATION FILE GRAPHIC 6 alzamendlogo_med.jpg GRAPHIC begin 644 alzamendlogo_med.jpg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htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
May 22, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 22, 2024
Entity File Number 001-40483
Entity Registrant Name ALZAMEND NEURO, INC.
Entity Central Index Key 0001677077
Entity Tax Identification Number 81-1822909
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3480 Peachtree Road NE
Entity Address, Address Line Two Second Floor
Entity Address, Address Line Three Suite 103
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30326
City Area Code (844)
Local Phone Number 722-6333
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol ALZN
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 25 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ALZN/role/Cover Cover Cover 1 false false All Reports Book All Reports alzn-20240522.xsd alzn-20240522_lab.xml alzn-20240522_pre.xml p5212408k.htm http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "p5212408k.htm": { "nsprefix": "ALZN", "nsuri": "http://ALZN/20240522", "dts": { "schema": { "local": [ "alzn-20240522.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "alzn-20240522_lab.xml" ] }, "presentationLink": { "local": [ "alzn-20240522_pre.xml" ] }, "inline": { "local": [ "p5212408k.htm" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 25 }, "report": { "R1": { "role": "http://ALZN/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "p5212408k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "p5212408k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ALZN/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001214659-24-009785-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-24-009785-xbrl.zip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end XML 18 p5212408k_htm.xml IDEA: XBRL DOCUMENT 0001677077 2024-05-22 2024-05-22 iso4217:USD shares iso4217:USD shares false 0001677077 8-K 2024-05-22 ALZAMEND NEURO, INC. DE 001-40483 81-1822909 3480 Peachtree Road NE Second Floor Suite 103 Atlanta GA 30326 (844) 722-6333 false false false false Common Stock, $0.0001 par value ALZN NASDAQ true false